Search results for: musculoskeletal disease

Advocacy Highlights & Fall Treats: Reflections from the GAC Chair

Elizabeth "Blair" Solow, MD | October 21, 2022

Outgoing Government Affairs Committee Chair Blair Solow, MD, offers advocacy updates from 2022 and seasonal reflections on how to stay focused on efforts that matter when faced with daunting challenges.

Lessons from Master Clinicians: An Interview with Dr. Gary Hoffman

Jason Liebowitz, MD, FACR | October 10, 2022

Rheumatologists who are outstanding clinicians, provide consistently exceptional care to patients and serve as role models for colleagues and trainees are in the spotlight in our Lessons from a Master Clinician series. Here, we offer insights from clinicians who have achieved a level of distinction in the field of rheumatology. Gary Hoffman, MD, MS, MACR,…

Sonographic Diagnosis of Knuckle Pads

Pankaj Bansal, MD, RhMSUS, Eugene Kissin, MD, RhMSUS, & Fawad Aslam, MBBS, RhMSUS, RMSK | October 10, 2022

The Case A 56-year-old white woman was evaluated for a one-year history of painless bumps on the dorsal aspect of the proximal interphalangeal (PIP) joints of both hands and suspected flexor tenosynovitis in her palms. On examination, small cystic nodules without erythema or tenderness were present on the dorsal aspect of several PIP joints (see…

Belimumab Promising for Children with Lupus Nephritis

Michele B. Kaufman, PharmD, BCGP | October 6, 2022

Belimumab is now FDA approved to treat children aged 5 years and older with active lupus nephritis, providing treatment options for pediatric patients at risk of developing renal damage.

Understanding the Role of Uric Acid in Gout

Ruth Jessen Hickman, MD | September 6, 2022

From the first substantial argument in the 19th century that uric acid played a role in gout, it took about 100 years for the medical community to accept its role in triggering acute inflammatory gout attacks. Two papers, both published in 1962, helped demonstrate the link between uric acid and acute gout attacks, quickly opening…

Rheumatologists Can & Should Help Combat Medical Misinformation

Kenneth G. Saag, MD, MSc | August 14, 2022

The Surgeon General has identified medical misinformation as a major public health threat, and many professional societies, including the American Medical Association, have called for action to combat it,” writes Richard J. Baron, MD, American Board of Internal Medicine (ABIM) chief executive officer, and Yul D. Ejnes, MD, ABIM’s board chair, in The New England…

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD | July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Baricitinib Promising for Juvenile Idiopathic Arthritis

Michele B. Kaufman, PharmD, BCGP | July 19, 2022

In a study from Ramanan et al., baricitinib proved safe and effective for reducing the time to flare and frequency of flare in patients aged 2–18 years with juvenile idiopathic arthritis.

Predicting the Future: Prognostication in Rheumatoid Arthritis

Jason Liebowitz, MD, FACR | July 19, 2022

A EULAR 2022 abstract session looked at several studies that seek to increase understanding of RA pathogenesis & identify patients at risk for disease progression.

Teaching Junior Learners in Rheumatology

Ian D. Cooley, MD, & Eli M. Miloslavsky, MD | July 13, 2022

Teaching junior learners, such as medical students and residents, is increasingly important in rheumatology. Given the anticipated shortage of rheumatologists, attracting more trainees to our field and enhancing knowledge of the rheumatic diseases among physicians in other fields are critical to meeting the needs of our patients.1,2 In addition, clinical reasoning is a vital skill…